Roche to acquire Kapa Biosystems
Roche announced that it has signed a definitive agreement to acquire Kapa Biosystems, Inc. (Kapa) a privately-held company headquartered in Wilmington, Massachusetts, US. Kapa Biosystems is a provider of genomic tools in the life sciences sector that employs proprietary technologies to optimize enzymes for next-generation sequencing (NGS), as well as polymerase chain reaction (PCR) and real-time PCR applications.
“Joining Roche provides us access to their broad product portfolio, global reach and clinical expertise that will accelerate our strategy of offering comprehensive NGS workflow solutions to more laboratories around the world,” said Paul McEwan, Co-Founder and Chief Scientific Officer of Kapa Biosystems. “We are also excited to have the opportunity to further leverage our enzyme engineering capabilities to advance the fields of genomics and sequencing, with the ultimate goal of having a more significant impact on medicine and human health.”
The transaction is subject to customary closing conditions. Financial terms of the transaction are not disclosed.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
Topic World PCR
This groundbreaking and highly versatile molecular technique of PCR allows us to amplify tiny amounts of genetic material on a large scale and analyze them in detail. Whether in medical diagnostics, forensic DNA analysis or research into genetic diseases - PCR is an indispensable tool that gives us deep insights into the world of DNA. Immerse yourself in the fascinating world of the polymerase chain reaction (PCR)!
Last viewed contents
A fungus converts cellulose directly into a novel platform chemical - A new process for the mass production of erythro-isocitric acid from waste could make the substance interesting for industry in the future
Galapagos enters into oncology target discovery collaboration with Janssen Pharmaceutica
Hitchhiking his way to better drug delivery - Harnessesing blood cells to help nanoparticles cross biological barriers
Dr. Christie Hunter wins HUPO 2013 Science and Technology Award - AB SCIEX proteomics scientist is recognized for her role in advancing targeted proteomics
Probiodrug Further Expands Scientific Advisory Board by Appointing Prof Dr Dr hc Christian Haass
Anti-tumor protein isolated from ink of a sea slug destroys various kinds of cancers
List_of_papaya_diseases
New 'NanoZymes' use light to kill bacteria - Artificial enzymes could be used in hospitals and toilets
Generex Publishes Results From Pre-Clinical Studies On Immunotherapeutic Vaccine for HPV-Induced Cervical Cancer
